These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 26575121)
1. Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy. Wang J; Duan L; Tian L; Liu J; Wang S; Gao Y; Yang J Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):417-23. PubMed ID: 26575121 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy. Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556 [TBL] [Abstract][Full Text] [Related]
3. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
4. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice. Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785 [TBL] [Abstract][Full Text] [Related]
6. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy. Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y Bioengineered; 2022 Jan; 13(1):634-644. PubMed ID: 34898373 [TBL] [Abstract][Full Text] [Related]
9. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy. Kang WL; Xu GS Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039 [TBL] [Abstract][Full Text] [Related]
10. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649 [TBL] [Abstract][Full Text] [Related]
11. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. Zhou L; Xu DY; Sha WG; Shen L; Lu GY; Yin X; Wang MJ J Transl Med; 2015 Nov; 13():352. PubMed ID: 26552447 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation. Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Kato M; Zhang J; Wang M; Lanting L; Yuan H; Rossi JJ; Natarajan R Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3432-7. PubMed ID: 17360662 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. Zhang Z; Peng H; Chen J; Chen X; Han F; Xu X; He X; Yan N FEBS Lett; 2009 Jun; 583(12):2009-14. PubMed ID: 19450585 [TBL] [Abstract][Full Text] [Related]
15. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21. Zhang L; He S; Yang F; Yu H; Xie W; Dai Q; Zhang D; Liu X; Zhou S; Zhang K Can J Physiol Pharmacol; 2016 Dec; 94(12):1249-1256. PubMed ID: 27704873 [TBL] [Abstract][Full Text] [Related]
16. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis. Park S; Moon S; Lee K; Park IB; Lee DH; Nam S Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545 [TBL] [Abstract][Full Text] [Related]
17. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling. Xin C; Xia Z; Jiang C; Lin M; Li G Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048 [TBL] [Abstract][Full Text] [Related]
18. Curcumin ameliorates Podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression. Li D; Lu Z; Jia J; Zheng Z; Lin S Kidney Blood Press Res; 2013; 38(1):61-71. PubMed ID: 24556741 [TBL] [Abstract][Full Text] [Related]
19. The decreased expression of electron transfer flavoprotein β is associated with tubular cell apoptosis in diabetic nephropathy. Wang H; Zhang H; Chen X; Zhao T; Kong Q; Yan M; Zhang B; Sun S; Lan HY; Li N; Li P Int J Mol Med; 2016 May; 37(5):1290-8. PubMed ID: 27035869 [TBL] [Abstract][Full Text] [Related]
20. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy. Yu R; Bo H; Villani V; Spencer PJ; Fu P Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]